Impact of Advanced Crohn's Disease Therapies on Sleep Quality
NCT07649408 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2026-06-16
Summary
The goal of this observational study is to measure changes in sleep quality before and after starting treatment with advance therapy in adult with Crohn disease. The main question it aims to answer is: what is the association between response to therapy and sleeping patterns? Participants who are about to begin advanced treatment will be asked to wear a Fitbit device before end after treatment initiation to monitor sleep patterns and sleep quality, complete a sleep diary and a sleep quality questionnaire. The follow-up period will last 26 weeks, during which disease severity and response to treatment will be assessed.
Conditions
- Crohn Disease (CD)
Interventions
- OTHER
-
Wearable activity and sleep tracker
Patients will be asked to wear the Fitbit inspire 3 on their non-dominant hand for consecutive 5 days, in three different time slots (before initiation of new treatment, at week 4 after initiation, and at week 8 after initiation)
Sponsors & Collaborators
-
Shmuel Kivity, MD
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-08-06
- Primary Completion
- 2027-10-31
- Completion
- 2027-12-31
Countries
- Israel
Study Locations
More Related Trials
-
Individualizing Anti-TNF Therapy in Patients With Inflammatory Bowel Disease
NCT07644117 ·Status: RECRUITING
-
Development of Workshop for Lifestyle Changing for Crohn's Disease Patients and Its Affect on the Disease's Indexes
NCT00376649 ·Status: WITHDRAWN ·Phase: NA
-
Anti TNF α Improves Endothelial Dysfunction in IBD Patients
NCT01881464 ·Status: UNKNOWN
-
Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease
NCT02162862 ·Status: COMPLETED ·Phase: PHASE4
-
RISE: A Remote Study of Insomnia Treatment in Crohn's Disease
NCT05956158 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effect of a Probiotic Mixture on the Gut Microbiome and Fatigue in Patients With Quiescent Inflammatory Bowel Disease
NCT03266484 ·Status: COMPLETED ·Phase: NA
-
Non-invasive Approaches to Identify the Cause of Fatigue in Inflammatory Bowel Disease Patients.
NCT03670693 ·Status: COMPLETED ·Phase: NA
-
Clinical Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Crohn's Disease
NCT07078994 ·Status: RECRUITING ·Phase: PHASE2
-
Inflammatory Bowel Disease Tracker (IBD Tracker)
NCT03953794 ·Status: WITHDRAWN
-
Study to Determine Relationship Between Serum Infliximab and Efficacy in Luminal Crohn's Disease Patients
NCT00676988 ·Status: COMPLETED
-
Immune Ablation and Stem Cell Support for Crohn's Disease
NCT00179842 ·Status: WITHDRAWN ·Phase: PHASE2
-
Circadian Rhythms in Patients With IBD or Celiac Disease Upon Diagnosis and Medical Follow-up
NCT03662646 ·Status: COMPLETED
-
The Assessment of Infrared Treatment for Crohn's Disease
NCT06146816 ·Status: RECRUITING ·Phase: NA
-
Stress in Crohn's Disease
NCT04809194 ·Status: COMPLETED
-
Observational Study of Disease Severity in Participants Diagnosed With Crohn's Disease and Long Term Impact of Treatment Strategies in Participants With Moderate to Severe Crohn's Disease (Protocol P06484)
NCT01218360 ·Status: COMPLETED
-
A Study of TAK-018 in Preventing the Recurrence of Crohn's Disease After Surgery
NCT03943446 ·Status: TERMINATED ·Phase: PHASE2
-
An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Crohn's Disease
NCT00269854 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
NCT06233461 ·Status: RECRUITING ·Phase: PHASE2
-
Anti-Tumor Necrosis Factor (TNF) Treatments, Work Productivity and Quality of Life in Crohn's Disease
NCT01860846 ·Status: COMPLETED
-
A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease
NCT02891226 ·Status: COMPLETED ·Phase: PHASE2
-
TITRATE (inducTIon for acuTe ulceRATivE Colitis)
NCT03937609 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluation of a Remote Monitoring Application in the Follow-up of Patients With Active Inflammatory Bowel Diseases
NCT06742385 ·Status: RECRUITING ·Phase: NA
-
Regulatory T-cells and Crohn's Disease
NCT02060318 ·Status: COMPLETED
-
Online Pain Education for Crohn's Disease and Ulcerative Colitis
NCT07671313 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF Therapy
NCT02365649 ·Status: COMPLETED ·Phase: PHASE2